I thought it rather interesting that two of the JSE’s most vaunted "game changers" — asset manager Sygnia and day-clinics developer Advanced Health — both detailed rights issues last week.
The companies need fresh capital for (very) different reasons: Sygnia to fund the recent acquisition of db X-trackers from Deutsche Group Holdings, and Advanced to shore up its strained balance sheet to continue its day clinic roll-out.